@article{chen:hal-02364994,
TITLE = {Early F-FDG PET/CT response predicts survival in Relapsed/Refractory Hodgkin Lymphoma treated with Nivolumab},
AUTHOR = {Chen, Aiping and Mokrane, Fatima-Zohra and Schwartz, Lawrence and Morschhauser, Franck and Stamatoullas, Apasia and Schiano de Colella, Jean-Marc and Vercellino, Laetitia and Casasnovas, Olivier and Chauchet, Adrien and Delmer, Alain and Nicolas-Virelizier, Emmanuelle and Ghesqui{\`e}res, Herv{\'e} and Moles-Moreau, Marie-Pierre and Schmitt, Anna and Dulery, R{\'e}my and Bouabdallah, Krimo and Borel, C{\'e}cile and Touati, Mohamed and Deau-Fischer, Benedicte and Peyrade, Fr{\'e}d{\'e}ric and Seban, Romain-David and Manson, Guillaume and Armand, Philippe and Houot, Roch and Dercle, Laurent},
URL = {https://univ-rennes.hal.science/hal-02364994},
JOURNAL = {Journal of Nuclear Medicine},
PUBLISHER = {Society of Nuclear Medicine},
VOLUME = {61},
NUMBER = {5},
PAGES = {649-654},
YEAR = {2020},
MONTH = May, DOI = {10.2967/jnumed.119.232827},
KEYWORDS = {anti-PD-1 ; hodgkin lymphoma ; immunotherapy ; nivolumab ; 18F-FDG PET ; Oncology Lymphoma ; Monoclonal Antibodies},
PDF = {https://univ-rennes.hal.science/hal-02364994/file/Chen%20et%20al-2019-Early%2018F-FDG%20PET-CT%20response%20predicts%20survival%20in%20Relapsed.pdf},
HAL_ID = {hal-02364994},
HAL_VERSION = {v1},
}